使用免疫细胞因子刺激抗瘤免疫反应:临床前和临床概述
Bart Boersma1,2, Hélène Poinot3,4, Aurélien Pommier5
1Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva, Switzerland.
Pharmaceutics
|August 29, 2024
概括
免疫细胞因子 (ICKs) 是工程蛋白质,可以将细胞因子直接传递给瘤,克服了癌症治疗传统细胞因子免疫疗法的局限性. 针对性技术的进步有望进一步提高ICK在临床试验中的有效性.
科学领域:
- 免疫学和癌症治疗疗法
- 生物技术和蛋白质工程 生物技术和蛋白质工程
背景情况:
- 细胞因子是强大的免疫调节剂和免疫治疗的基石,但它们在癌症中的临床应用受到药理动力学和不良副作用的阻碍.
- 免疫细胞因子 (ICK) 是一种创新策略,可以增强细胞因子向瘤微环境的输送,利用免疫球蛋白支架来提高稳定性和特异性.
研究的目的:
- 在癌症治疗中利用关键细胞因子 (IL-2,TNFα,IL-10,IL-12,IL-15,IL-21,IFNγ,GM-CSF,IFNα) 的免疫细胞因子 (ICK) 的发展和治疗潜力进行审查.
- 根据其技术设计,分析ICKs的免疫调节作用,并将其与裸体细胞因子进行比较.
主要方法:
- 关于免疫细胞因子 (ICKs) 和它们在癌症治疗中的应用的现有文献的全面审查.
- 专注于用特定的细胞因子和相关的基于免疫球蛋白的支架设计的ICK.
- 分析各种ICK设计的药理作用和免疫调节特性.
主要成果:
- 审查的ICK包括IL-2,TNFα,IL-10,IL-12,IL-15,IL-21,IFNγ,GM-CSF和IFNα等细胞因子,在临床前和临床癌症研究中显示出潜力.
- ICK的技术设计显著影响其免疫调节效应和瘤向能力.
- 目前正在进行的临床试验有希望的结果突出显示了ICKs的治疗潜力.
结论:
- 免疫细胞因子 (ICKs) 为克服常规细胞因子免疫治疗癌症的局限性提供了一个有希望的策略.
- 目标技术的持续进步,包括细胞因子/链接器工程和多种类型抗体设计,预计将进一步提高ICK的疗效.
- 未来ICK设计的发展具有提高瘤向和癌症治疗中的免疫刺激性能的巨大潜力.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.7K
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:27Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K